| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $145K | +98.7% | +185.9% |
| Cost of Revenue | $53K | +1055.6% | +253.4% |
| Gross Profit | $92K | +34.5% | +157.6% |
| R&D Expense | $165K | +208.7% | -53.8% |
| SG&A Expense | $4.5M | -4.8% | +127.4% |
| Operating Income | -$4.7M | +5.2% | +91.9% |
| Net Income | $1.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $147K | +205.7% | +74.1% |
| Inventory | $9.6M | +1.6% | +19.9% |
| Current Assets | $16.3M | +7.1% | -57.2% |
| Total Assets | $29.5M | +3.0% | -34.5% |
| Current Liabilities | $28.4M | -10.2% | +35.1% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.5M | — | — |
| Capital Expenditures | $33K | — | — |
| Investing Cash Flow | -$225K | — | — |
| Financing Cash Flow | $11.1M | — | — |
| Free Cash Flow | -$11.5M | — | — |
| +118.6% |
| +104.1% |
| EPS (Basic) | $0.03 | +115.8% | +102.0% |
| EPS (Diluted) | $0.03 | +115.8% | +102.0% |
| $33.7M |
| -14.7% |
| -36.4% |
| Stockholders' Equity | -$4.3M | +61.0% | +46.7% |